About Aier

  愛爾眼科醫院集團是知名全球連鎖眼科醫療機構,IPO上市醫療機構(股票代码: 300015,2015年入选沪深300指数股)。截至2019年,已在中國大陸30個省市區建立300余家專業眼科醫院,覆蓋全國醫保人口超過70%,年門診量超过650 万人。並且,美國、歐洲和中國香港開設有80余家眼科醫院

  Aier eye hospital group is a well-known global chain of eye hospitals, and is also China's first IPO listed medical institution (stock code: 300015, one of the CSI 300 index selected in 2015). As of 2019, Aier Eye Hospital Group has established more than 300 specialized eye hospitals covering 30 provinces and extended our services to 70% of insured population all over the country with over 6.5 million outpatient visits annually. Recently, There are more than 80 ophthalmic branches in the United States, Europe and Hongkong,China.


  Aier is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance the development of China's ophthalmic medical care.


  Base on constant exploration and practice, also with absorb advanced international medical management experience, Aier Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country.


  In 2013, Aier and Central South University jointly set up Aier School of ophthalmology, CSU, to educate and train medical professionals with advanced degrees; Once again in 2014, Aier joined the Hubei University of Science and Technology to establish the Aier School of Ophthalmology & Optometry. In 2011 and 2015, Aier established the Aier Institute of Optometry and Aier Institute of Ophthalmology respectively. At this point, Aier has bridged all three areas of medicine, education and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.


  As of 2016, Aier has recruited and trained over 3000 doctors and specialized experts, many of whom have studied in elite institutions in Europe and the US. They are China’s driving force in ophthalmology.


  On July 9,2014, the President of the World Bank Jim Yong Kim visited Changsha Aier Eye Hospital and promoted Aier’s unique sustainable philanthropic model in developing countries. In 2015, Aier acquired Hong Kong Asia Medical Group and paved the way for Aier’s internationalization. In early 2017, Aier acquired a renowned eyecare center in American, which brought Aier’s international expansion to a new stage.


  Since its founding, Aier always committed to the mission, “Everyone in everywhere, we do care “. With its "cross subsidy" model, Aier provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness.

  隨著中國醫療衛生體制改革的進一步推進,愛爾眼科順應國家醫療衛生政策和發展趨勢,于2014年在醫療行業推出“合夥人計劃”,致力于改变眼科医生执业的生态环境,最大限度地激发核心骨干的创造力和能动性。愛爾眼科专注于眼科医疗服务事业,预计到 2020年,兴建1000家具有競爭力的專業連鎖眼科醫院,爲更多的人提供高質量、多層次的眼科醫療服務。

  In 2014, Aier launched the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members. It is expected that by the end of 2020, Aier will have 1000 eye hospitals which provide high quality and multi-level eye care to more people.

请关注公众号:aierhospital ,爱眼护眼早知道。